BRIEF

on ICADE (EPA:ICAD)

Icade Completes €350 Million Cash Tender Offer

Stock price chart of ICADE (EPA:ICAD) showing fluctuations.

Icade has successfully completed its cash tender offer, initially launched on May 14, 2024, to purchase three series of existing notes. The company has repurchased a total of €350 million out of €517.1 million tendered.

A breakdown of the repurchases includes €142.5 million from the €500 million notes maturing on November 17, 2025, with a 1.125% coupon. Additionally, €207.5 million was repurchased from the €750 million notes maturing on June 10, 2026, with a 1.75% coupon. The €600 million notes, scheduled to mature on September 13, 2027, were not repurchased.

HSBC Continental Europe and Société Générale served as bookrunners for the tender offer. The settlement is scheduled for May 28, 2024.

This strategic move aligns with Icade's ReShapE plan announced in February 2024. The company is using proceeds from the 2023 disposal of its healthcare activities to manage its debt maturity profile proactively.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all ICADE news